Stocks
First Tracks Biotherapeutics, Inc.TRAX
NASDAQHealthcareBiotechnology$43.14
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing first-in-class therapies for autoimmune and inflammatory diseases. Its lead programs target validated pathways with novel mechanisms, and investors track it for its pipeline catalysts and potential in high-demand therapeutic areas.
52W Range: $14.72-$49.91
Congressional Interest in First Tracks Biotherapeutics, Inc. (TRAX)
No congressional trades have been disclosed for First Tracks Biotherapeutics, Inc. (TRAX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TRAX?
No congressional trades found for this stock.